Product
Biological
1 clinical trial
2 indications
Indication
NeuroblastomaIndication
Pediatric solid tumorsClinical trial
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid TumorsStatus: Recruiting, Estimated PCD: 2027-08-25